Needham & Company Downgrades GW Pharma (GWPH) to Hold, Following Acquisition
Tweet Send to a Friend
Needham & Company analyst Serge Belanger downgraded GW Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
